1-1 of 1
Hiroki Amagase
Close
Sort by
Journal Articles

Persistent ADAMTS13 inhibitor delays recovery of ADAMTS13 activity in caplacizumab-treated Japanese patients with iTTP

Kenki Saito, Kazuya Sakai, Masayuki Kubo, Hidekazu Azumi, Atsushi Hamamura, Shinichi Ochi, Hiroki Amagase, Hisako Kunieda, Yoshiyuki Ogawa, Hideo Yagi, Masanori Matsumoto
Journal: Blood Advances
Blood Adv (2024) 8 (9): 2151–2159.
https://doi.org/10.1182/bloodadvances.2023012451
Published: 2024
Includes: Supplemental data